Stay updated on ADVM-022 Gene Therapy for Wet AMD Clinical Trial
Sign up to get notified when there's something new on the ADVM-022 Gene Therapy for Wet AMD Clinical Trial page.

Latest updates to the ADVM-022 Gene Therapy for Wet AMD Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe ClinicalTrials.gov record for the completed Phase 1 ADVM-022 gene therapy study for wet AMD is displayed, including its study design, eligibility criteria, locations, outcome measures, and publication information.SummaryDifference52%

- Check16 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA banner announces that NIH is transitioning to use “Super Intelligence” in place of “Artificial Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer's site revision identifier advances from v3.7.1 to v3.7.2 while the page remains a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer's site revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the expected study content and indicating an access issue with loading the study record. This reflects an access problem rather than a substantive update to the study information.SummaryDifference18%

Stay in the know with updates to ADVM-022 Gene Therapy for Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVM-022 Gene Therapy for Wet AMD Clinical Trial page.